SCHEMBL6832737

SCHEMBL6832737

N[C@@H](CC(=O)CO)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.55
SLC7A11 Q9UPY5 1/20 0.55
GRIK1 P39086 9/20 0.52
GRIK2 Q13002 6/20 0.52
SLC1A1 P43005 4/20 0.52
GRM1 Q13255 2/20 0.52
GRM2 Q14416 2/20 0.52
SLC7A5 Q01650 1/20 0.50
GGT1 P19440 4/20 0.46
GRIA4 P48058 4/20 0.45
GRIK3 Q13003 4/20 0.45
GRIK5 Q16478 4/20 0.45
SLC1A3 P43003 3/20 0.44
SLC1A2 P43004 3/20 0.44
GRIA2 P42262 3/20 0.44
GRIA1 P42261 2/20 0.44
GRM8 O00222 1/20 0.44
GRM6 O15303 1/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10618897 1.00 PTGS1 (0.55) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL31260122 0.82 GRIK1 (0.46) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL31670693 0.82 GRIK1 (0.46) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL7366965 0.81 GRIK1 (0.50) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL564563 0.81 GRIK1 (0.50) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL3145928 0.81 GRIK1 (0.50) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL3044802 0.81 GRIK1 (0.50) PTGS1SLC7A11GRIK1GRIK2SLC1A1
Aspartic Acid SCHEMBL28538562 0.80 GRIK1 (0.54) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL23829840 0.79 GRIK1 (0.48) PTGS1SLC7A11GRIK1GRIK2SLC1A1
SCHEMBL6598328 0.79 GRIK1 (0.48) PTGS1SLC7A11GRIK1GRIK2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4680311-A Method for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO., LTD. (JP) 1987-07-14 US claimed
EP-0202778-A2 Use of (S)-2-amino-5-hydroxy-4-oxopentanoic acid for the preparation of a medicament for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO. LTD (JP) 1986-11-26 EP claimed
JP-61243018-A None JP disclosed
US-9012567-B2 Supramolecular polymers and compositions containing said polymers RHODIA OPERATIONS (FR) 2015-04-21 US disclosed
US-8986399-B2 Treating lignocellulosic materials EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2015-03-24 US disclosed
US-20120297555-A1 TREATING LIGNOCELLULOSIC MATERIALS EMPIRE TECHNOLOGY DEVELOPMENT LLC 2012-11-29 US disclosed
US-20120289652-A1 SUPRAMOLECULAR POLYMERS AND COMPOSITIONS CONTAINING SAID POLYMERS RHODIA OPERATIONS (FR) 2012-11-15 US disclosed
US-6743432-B1 MEMBRANE HAVING LOW ADSORPTIVITY FOR PROTEIN; HOMO- OR CO-POLYMER OF FLUORINE-CONTAINING MONOMER INCLUDING HYDROPHILIC GROUP, HYDROPHILIZED POLYSULFONE INCORPORATING WETTING AGENT, HYDROPHILIZED CELLULOSE DERIVATIVE HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2004-06-01 US disclosed
EP-0747092-B1 Matrix for iontophoresis HISAMITSU PHARMACEUTICAL CO (JP) 2003-12-03 EP disclosed
EP-0748636-B1 Interface for iontophoresis HISAMITSU PHARMACEUTICAL CO (JP) 2003-08-27 EP disclosed
EP-0950407-B1 The use of a GP IIb/IIIa antagonist for the manufacture of a medicament suitable for transdermal application by iontophoresis HISAMITSU PHARMACEUTICAL CO (JP) 2002-09-04 EP disclosed
EP-0638588-A1 Derivatives of 6,7-Dihydroxy-4-thiaheptonic acid and their use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-15 EP disclosed
EP-0604945-A1 TAN-1511, its derivatives, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-07-06 EP disclosed
EP-0604957-A1 2-Amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-07-06 EP disclosed
EP-0202778-A3 Use of (S)-2-amino-5-hydroxy-4-oxopentanoic acid for the preparation of a medicament for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO. LTD (JP) 1988-11-17 EP disclosed
US-4680311-A Method for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO., LTD. (JP) 1987-07-14 US disclosed
US-4680311-A Method for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO., LTD. (JP) 1987-07-14 US disclosed
EP-0202778-A2 Use of (S)-2-amino-5-hydroxy-4-oxopentanoic acid for the preparation of a medicament for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO. LTD (JP) 1986-11-26 EP disclosed
EP-0202778-A2 Use of (S)-2-amino-5-hydroxy-4-oxopentanoic acid for the preparation of a medicament for the treatment of systemic mycosis TAISHO PHARMACEUTICAL CO. LTD (JP) 1986-11-26 EP disclosed
JP-S61243018-A REMEDY FOR MYCOSIS TAISHO PHARMACEUT CO LTD 1986-10-29 JP disclosed